132 related articles for article (PubMed ID: 9845525)
1. Adenovirus vector-based purging of multiple myeloma cells.
Teoh G; Chen L; Urashima M; Tai YT; Celi LA; Chen D; Chauhan D; Ogata A; Finberg RW; Webb IJ; Kufe DW; Anderson KC
Blood; 1998 Dec; 92(12):4591-601. PubMed ID: 9845525
[TBL] [Abstract][Full Text] [Related]
2. Breast cancer selective gene expression and therapy mediated by recombinant adenoviruses containing the DF3/MUC1 promoter.
Chen L; Chen D; Manome Y; Dong Y; Fine HA; Kufe DW
J Clin Invest; 1995 Dec; 96(6):2775-82. PubMed ID: 8675647
[TBL] [Abstract][Full Text] [Related]
3. Adenovirus-mediated suicide gene therapy under the control of Cox-2 promoter for colorectal cancer.
Wang ZX; Bian HB; Yang JS; De W; Ji XH
Cancer Biol Ther; 2009 Aug; 8(15):1480-8. PubMed ID: 19571664
[TBL] [Abstract][Full Text] [Related]
4. Selectivity of a replication-competent adenovirus for human breast carcinoma cells expressing the MUC1 antigen.
Kurihara T; Brough DE; Kovesdi I; Kufe DW
J Clin Invest; 2000 Sep; 106(6):763-71. PubMed ID: 10995787
[TBL] [Abstract][Full Text] [Related]
5. In vivo cytotoxicity of ovarian cancer cells through tumor-selective expression of the BAX gene.
Tai YT; Strobel T; Kufe D; Cannistra SA
Cancer Res; 1999 May; 59(9):2121-6. PubMed ID: 10232598
[TBL] [Abstract][Full Text] [Related]
6. Adenoviral vectors efficiently target cell lines derived from selected lymphocytic malignancies, including anaplastic large cell lymphoma and Hodgkin's disease.
Meeker TC; Lay LT; Wroblewski JM; Turturro F; Li Z; Seth P
Clin Cancer Res; 1997 Mar; 3(3):357-64. PubMed ID: 9815692
[TBL] [Abstract][Full Text] [Related]
7. Selective elimination (purging) of contaminating malignant cells from hematopoietic stem cell autografts using recombinant adenovirus.
Wroblewski JM; Lay LT; Van Zant G; Phillips G; Seth P; Curiel D; Meeker TC
Cancer Gene Ther; 1996; 3(4):257-64. PubMed ID: 8853551
[TBL] [Abstract][Full Text] [Related]
8. Combined antitumor effects of an adenoviral cytosine deaminase/thymidine kinase fusion gene in rat C6 glioma.
Chang JW; Lee H; Kim E; Lee Y; Chung SS; Kim JH
Neurosurgery; 2000 Oct; 47(4):931-8; discussion 938-9. PubMed ID: 11014433
[TBL] [Abstract][Full Text] [Related]
9. Purging of contaminating breast cancer cells from hematopoietic stem cell grafts by adenoviral GAL-TEK gene therapy and magnetic antibody cell separation.
Marini FC; Snell V; Yu Q; Zhang X; Singletary SE; Champlin R; Andreeff M
Clin Cancer Res; 1999 Jun; 5(6):1557-68. PubMed ID: 10389945
[TBL] [Abstract][Full Text] [Related]
10. Gene therapy utilizing the Cre/loxP system selectively suppresses tumor growth of disseminated carcinoembryonic antigen-producing cancer cells.
Goto H; Osaki T; Kijima T; Nishino K; Kumagai T; Funakoshi T; Kimura H; Takeda Y; Yoneda T; Tachibana I; Hayashi S
Int J Cancer; 2001 Nov; 94(3):414-9. PubMed ID: 11745423
[TBL] [Abstract][Full Text] [Related]
11. Targeted expression of herpes simplex virus thymidine kinase in adenovirus-infected cells reduces virus titers upon treatment with ganciclovir in vitro.
Ibrišimović M; Nagl U; Kneidinger D; Rauch M; Lion T; Klein R
J Gene Med; 2012 Jan; 14(1):3-19. PubMed ID: 22190534
[TBL] [Abstract][Full Text] [Related]
12. Construction of a novel oncolytic adenoviral vector and its biological characteristics.
Zhang M; Zhang X; Han Z; Chen X; Yang L; Sheng Y; Wen J
Oncol Rep; 2013 Feb; 29(2):798-804. PubMed ID: 23165979
[TBL] [Abstract][Full Text] [Related]
13. Treatment of malignant gliomas with a replicating adenoviral vector expressing herpes simplex virus-thymidine kinase.
Nanda D; Vogels R; Havenga M; Avezaat CJ; Bout A; Smitt PS
Cancer Res; 2001 Dec; 61(24):8743-50. PubMed ID: 11751394
[TBL] [Abstract][Full Text] [Related]
14. Selective transgene expression for detection and elimination of contaminating carcinoma cells in hematopoietic stem cell sources.
Chen L; Pulsipher M; Chen D; Sieff C; Elias A; Fine HA; Kufe DW
J Clin Invest; 1996 Dec; 98(11):2539-48. PubMed ID: 8958216
[TBL] [Abstract][Full Text] [Related]
15. Adenoviral-mediated herpes simplex virus-thymidine kinase gene transfer in vivo for treatment of experimental human melanoma.
Bonnekoh B; Greenhalgh DA; Bundman DS; Kosai K; Chen SH; Finegold MJ; Krieg T; Woo SL; Roop R
J Invest Dermatol; 1996 Jun; 106(6):1163-8. PubMed ID: 8752651
[TBL] [Abstract][Full Text] [Related]
16. Adenoviral-mediated delivery of the herpes simplex virus thymidine kinase gene selectively sensitizes human ovarian carcinoma cells to ganciclovir.
Rosenfeld ME; Feng M; Michael SI; Siegal GP; Alvarez RD; Curiel DT
Clin Cancer Res; 1995 Dec; 1(12):1571-80. PubMed ID: 9815958
[TBL] [Abstract][Full Text] [Related]
17. Enhancer sequences of the DF3 gene regulate expression of the herpes simplex virus thymidine kinase gene and confer sensitivity of human breast cancer cells to ganciclovir.
Manome Y; Abe M; Hagen MF; Fine HA; Kufe DW
Cancer Res; 1994 Oct; 54(20):5408-13. PubMed ID: 7923173
[TBL] [Abstract][Full Text] [Related]
18. GCV modulates the antitumoural efficacy of a replicative adenovirus expressing the Tat8-TK as a late gene in a pancreatic tumour model.
Cascante A; Abate-Daga D; Garcia-Rodríguez L; González JR; Alemany R; Fillat C
Gene Ther; 2007 Oct; 14(20):1471-80. PubMed ID: 17713568
[TBL] [Abstract][Full Text] [Related]
19. Fibroblast growth factor-2-retargeted adenoviral vector for selective transduction of primary glioblastoma multiforme endothelial cells.
Gupta V; Wang W; Sosnowski BA; Hofman FM; Chen TC
Neurosurg Focus; 2006 Apr; 20(4):E26. PubMed ID: 16709032
[TBL] [Abstract][Full Text] [Related]
20. Thymidine kinase (TK) gene-transduced human lymphocytes can be highly purified, remain fully functional, and are killed efficiently with ganciclovir.
Munshi NC; Govindarajan R; Drake R; Ding LM; Iyer R; Saylors R; Kornbluth J; Marcus S; Chiang Y; Ennist D; Kwak L; Reynolds C; Tricot G; Barlogie B
Blood; 1997 Feb; 89(4):1334-40. PubMed ID: 9028956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
